Янкова, Р. Приложение на локален такролимус при себореен дерматит на лицето - реактивно и проактивно. // Дерматол. и венерол., 2014;52(1):35-47.
Alizadeh N, Monadi Nori H, Golchi J, Eshkevari SS, Kazemnejad E, Darjani A. Comparison the efficacy of fluconazole and terbinafine in patients with moderate to severe seborrheic dermatitis.- Dermatol. Res. Pract., 2014;2014:705402. doi: 10.1155/2014/705402.
Bikowski J. Facial seborrheic dermatitis: a report on current status and therapeutic horizons.- J. Drugs Dermatol., 2009;8(2):125-133.
Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis.- Am. Fam. Physician. 2015;91(3):185-190.
Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebocontrolled study.- Am. J. Clin. Dermatol., 2007;8(4):235-238.
Dall’Oglio F, Lacarrubba F, Verzì AE, Micali G. Noncorticosteroid combination shampoo versus 1% ketoconazole shampoo for the management of mild-to-moderate seborrheic dermatitis of the scalp: Results from a randomized, investigator-single-blind trial using clinical and trichoscopic evaluation.- Skin Appendage Disord., 2016;1(3):126-130.
Dall’oglio F, Tedeschi A, Fusto CM, Lacarrubba F, Dinotta F, Micali G. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: a open-label trial utilizing clinical evaluation and erythema directed digital photography.- G. Ital. Dermatol. Venereol., 2017 Jan 24. doi: 10.23736/S0392-0488.17.05539-0.
de Souza Leão Kamamoto C, Sanudo A, Hassun KM, Bagatin E. Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial.- Int. J. Dermatol., 2017;56(1):80-85.
Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.- Clin. Dermatol., 2013;31(4):343-351.
Gupta AK, Versteeg SG. Topical treatment of facial seborrheic dermatitis: a systematic review.- Am. J. Clin. Dermatol., 2016 Nov 2. doi: 10.1007/s40257-016-0232-2.
Hald M, Arendrup MC, Svejgaard EL, Lindskov R, Foged EK, Saunte DM; Danish Society of Dermatology. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases.- Acta Derm. Venereol., 2015;95(1):12-19.
Kastarinen H, Oksanen T, Okokon EO, Kiviniemi VV, Airola K, Jyrkkä J, Oravilahti T, Rannanheimo PK, Verbeek JH. Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp.- Cochrane Database Syst. Rev., 2014 May 19;(5):CD009446. doi: 10.1002/14651858. CD009446.pub2.
Kastarinen, H., E. O. Okokon, J. H. Verbeek. Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review.- JAMA Dermatol., 2015;151(2):221-222.
Kwon SH, Jeong MY, Park KC, Youn SW, Huh CH, Na JI. A new therapeutic option for facial seborrhoeic dermatitis: indole-3-acetic acid photodynamic therapy.- J. Eur. Acad. Dermatol. Venereol., 2014;28(1):94-99.
Prohic A, Jovovic Sadikovic T, Krupalija- Fazlic M, Kuskunovic-Vlahovljak S. Malassezia species in healthy skin and in dermatological conditions.- Int. J. Dermatol., 2016;55(5):494-504.
Schwartz JR. Zinc pyrithione: a topical antimicrobial with complex pharmaceutics.- J. Drugs Dermatol., 2016;15(2):140-144.
Shemer A, Kaplan B, Nathansohn N, Grunwald MH, Amichai B, Trau H. Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study.- Isr. Med. Assoc. J., 2008;10(6):417-418.
Stefanaki I, Katsambas A. Therapeutic update on seborrheic dermatitis.- Skin Therapy Lett., 2010;15(5):1-4.